Evidence map›Paper›PMID 42653458›Full record

ReviewInternational journal of molecular sciences2026

Thieno[3,2-

Anvarjon Buronov, Shukhrat Gaybullaev, Zarifa Murtazaeva, Feruza Ruzieva, Zohidjon Khushnazarov, Davron Turgunov, Azizbek Nasrullaev, Rustamkhon Kuryazov, Yuldash Takhirov, Firdavsi Tursunov and 13 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Anvarjon BuronovDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.ORCID 0000-0003-1887-6804
Shukhrat GaybullaevDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.ORCID 0009-0003-7753-4262
Zarifa MurtazaevaDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.
Feruza RuzievaDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.
Zohidjon KhushnazarovDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.
Davron TurgunovDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.
Azizbek NasrullaevDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.
Rustamkhon KuryazovDepartment of Chemistry, Urgench State University named after Abu Rayhan Biruni, Kh. Olimjon st. 14, Urgench 220100, Uzbekistan.
Yuldash TakhirovDepartment of Chemistry, Urgench State University named after Abu Rayhan Biruni, Kh. Olimjon st. 14, Urgench 220100, Uzbekistan.ORCID 0000-0001-5281-9446
Firdavsi TursunovDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.
Temur KushatovDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.
Dilshod DushamovDepartment of Chemistry, Urgench State University named after Abu Rayhan Biruni, Kh. Olimjon st. 14, Urgench 220100, Uzbekistan.ORCID 0000-0001-7971-9752
Shavkat MatmuratovDepartment of Chemistry, Urgench State University named after Abu Rayhan Biruni, Kh. Olimjon st. 14, Urgench 220100, Uzbekistan.
Nilufar NurullaevaDepartment of Chemistry, Urgench State University named after Abu Rayhan Biruni, Kh. Olimjon st. 14, Urgench 220100, Uzbekistan.
Aziza ShodikulovaSamarkand State Medical University, Amir Temur st. 18, Samarkand 140100, Uzbekistan.
Kakhor KhalikovSamarkand State Medical University, Amir Temur st. 18, Samarkand 140100, Uzbekistan.
Dilafruz KholmurodovaScientific and Practical Center of Immunology, Allergology and Human Genomics, Samarkand State Medical University, Makhdūm-i A'ẓam st. 18, Samarkand 140104, Uzbekistan.
Sodik NumonovDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.ORCID 0000-0003-4597-4047
Chao NiuState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, South Beijing Rd 40-1, Urumqi 830011, China.ORCID 0000-0001-5943-6771
Yuanyuan JiDepartment of Geriatric General Surgery, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710004, China.
Jiangyu ZhaoState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, South Beijing Rd 40-1, Urumqi 830011, China.
Zhishen GeSchool of Chemistry, State Key Laboratory of Fluorine & Nitrogen Chemicals, Institute of New Concept Sensors and Molecular Materials (INCSMM), Engineering Research Center of Energy Storage Materials and Devices, Ministry of Education, Xi'an Key Laboratory of Sustainable Polymer Materials, Xi'an Jiaotong University, Xi'an 710049, China.ORCID 0000-0002-2668-6974
Khurshed BozorovDepartment of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand 140104, Uzbekistan.ORCID 0000-0001-7449-0936

Funding

Organization of the Laboratory for the Creation of anticancer drugs ALM-202310062530Xinjiang International Science & Technology Cooperation Key Program 2025E01054
6 · The paper itself

Abstract

The thieno[3,2-

Indexed as

Antineoplastic AgentsDrug DesignDrug DiscoveryNeoplasmsPyrimidinesAnimalsHumansStructure-Activity RelationshipAntineoplastic AgentsPyrimidinesanticancer agentsCDK inhibitorsdual-target inhibitorsEGFR inhibitorsolmutinibPI3K/mTOR inhibitorspictilisibstructure–activity relationshipthieno [3,2-d]pyrimidinesthiophene

Identifiers

PMID42653458
PMCPMC13512955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.